Adiposity, CVD Risk Factors and Testosterone: Variation by Partnering Status and Residence with Children in US Men
Overview
Affiliations
In many settings, partnered, invested fathers have lower testosterone than single men or fathers who are not involved in caregiving. Reduced testosterone has been identified as a risk factor for multiple chronic diseases, and men's health also commonly varies by life history status. There have been few tests of whether variation in testosterone based on partnering and parenting has implications for men's health. We analysed data from a US population-representative sample (NHANES) of young-to-middle aged US men ( = 875; mean age: 29.8 years ± 6.0 [SD]). We tested for life history status differences in testosterone, adiposity levels and biomarkers of cardiovascular disease (CVD)-risk (HDL cholesterol; triglycerides; white blood cell count [WBC]). Partnered men residing with children (RC) had lower testosterone and elevated abdominal adiposity compared to never married men not residing with children. While they did not significantly differ for WBC or triglycerides, partnered RC men also had comparatively lower HDL. Partnered RC males' lower testosterone accounted for their relatively elevated adiposity, but testosterone, adiposity, and health-related covariates did not explain their relatively reduced HDL. Our results linking life history status-based differences in testosterone and adiposity, alongside our complementary HDL findings, indicate that testosterone-related psychobiology might have implications for partnered RC men's CVD risk in the US and other similar societal settings. These types of socially contextualized observations of men's health and physiological function particularly merit incorporation in clinical discussions of fatherhood as a component of men's health.
Baxter S, Hopper L, Spinner C Am J Mens Health. 2024; 18(2):15579883241239770.
PMID: 38545885 PMC: 10981246. DOI: 10.1177/15579883241239770.
Healthy Dads, Healthy Kids UK, a weight management programme for fathers: feasibility RCT.
Griffin T, Sun Y, Sidhu M, Adab P, Burgess A, Collins C BMJ Open. 2019; 9(12):e033534.
PMID: 31826896 PMC: 6924741. DOI: 10.1136/bmjopen-2019-033534.
Gettler L, Sarma M, Lew-Levy S, Bond A, Trumble B, Boyette A Brain Behav. 2019; 9(9):e01367.
PMID: 31385447 PMC: 6749485. DOI: 10.1002/brb3.1367.